Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hearing Loss, Noise-Induced | 11 | 2022 | 46 | 5.960 |
Why?
|
Cochlea | 18 | 2020 | 167 | 3.710 |
Why?
|
Hair Cells, Auditory | 17 | 2019 | 60 | 3.570 |
Why?
|
Mice, Inbred CBA | 20 | 2019 | 107 | 1.870 |
Why?
|
Deafness | 3 | 2022 | 63 | 1.760 |
Why?
|
Hair Cells, Auditory, Outer | 9 | 2022 | 33 | 1.460 |
Why?
|
Hearing Loss | 6 | 2022 | 154 | 1.430 |
Why?
|
Noise | 6 | 2016 | 153 | 1.350 |
Why?
|
Antioxidants | 6 | 2016 | 304 | 1.320 |
Why?
|
Cell Death | 8 | 2022 | 329 | 1.280 |
Why?
|
Oxidative Stress | 7 | 2015 | 718 | 1.130 |
Why?
|
Mice | 30 | 2020 | 8461 | 1.100 |
Why?
|
Gentamicins | 7 | 2013 | 68 | 1.010 |
Why?
|
Ear, Inner | 4 | 2016 | 47 | 1.000 |
Why?
|
Aging | 5 | 2011 | 909 | 0.930 |
Why?
|
RNA, Small Interfering | 5 | 2022 | 434 | 0.930 |
Why?
|
Animals | 37 | 2022 | 20849 | 0.930 |
Why?
|
AMP-Activated Protein Kinases | 3 | 2022 | 48 | 0.920 |
Why?
|
Organ of Corti | 3 | 2019 | 21 | 0.890 |
Why?
|
Hair Cells, Auditory, Inner | 2 | 2019 | 19 | 0.780 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2015 | 331 | 0.770 |
Why?
|
Microdissection | 1 | 2019 | 15 | 0.740 |
Why?
|
Azepines | 1 | 2019 | 15 | 0.710 |
Why?
|
Hydrogen Peroxide | 1 | 2019 | 168 | 0.700 |
Why?
|
Presbycusis | 2 | 2011 | 82 | 0.700 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2019 | 33 | 0.690 |
Why?
|
Anti-Bacterial Agents | 10 | 2020 | 1026 | 0.680 |
Why?
|
Quinazolines | 1 | 2019 | 70 | 0.680 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 9 | 2016 | 49 | 0.670 |
Why?
|
Hydroxamic Acids | 2 | 2016 | 84 | 0.640 |
Why?
|
Apoptosis | 4 | 2017 | 1639 | 0.640 |
Why?
|
Signal Transduction | 6 | 2016 | 2686 | 0.640 |
Why?
|
Gene Transfer Techniques | 2 | 2022 | 173 | 0.640 |
Why?
|
Auditory Threshold | 8 | 2019 | 205 | 0.600 |
Why?
|
Autophagy | 2 | 2017 | 207 | 0.590 |
Why?
|
Actins | 3 | 2019 | 249 | 0.580 |
Why?
|
Hearing Loss, Sensorineural | 4 | 2013 | 110 | 0.550 |
Why?
|
Sirolimus | 2 | 2017 | 118 | 0.540 |
Why?
|
rho-Associated Kinases | 1 | 2015 | 32 | 0.530 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2016 | 116 | 0.530 |
Why?
|
GTPase-Activating Proteins | 1 | 2014 | 21 | 0.510 |
Why?
|
DNA-Binding Proteins | 2 | 2016 | 697 | 0.500 |
Why?
|
Nebramycin | 3 | 2020 | 3 | 0.500 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2014 | 30 | 0.500 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2015 | 221 | 0.490 |
Why?
|
Gene Expression Regulation | 3 | 2016 | 1290 | 0.460 |
Why?
|
rac GTP-Binding Proteins | 1 | 2012 | 8 | 0.460 |
Why?
|
Acoustic Stimulation | 5 | 2016 | 206 | 0.450 |
Why?
|
rho GTP-Binding Proteins | 1 | 2012 | 19 | 0.450 |
Why?
|
Cell Survival | 2 | 2013 | 901 | 0.450 |
Why?
|
Homeodomain Proteins | 1 | 2013 | 157 | 0.440 |
Why?
|
RNA Interference | 1 | 2012 | 266 | 0.420 |
Why?
|
Neuropeptides | 1 | 2012 | 106 | 0.420 |
Why?
|
Male | 22 | 2019 | 37265 | 0.410 |
Why?
|
Energy Metabolism | 1 | 2012 | 222 | 0.390 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2013 | 626 | 0.390 |
Why?
|
Transcription Factors | 1 | 2015 | 751 | 0.390 |
Why?
|
Phosphatidylinositol Phosphates | 1 | 2009 | 6 | 0.370 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2009 | 32 | 0.350 |
Why?
|
Dietary Supplements | 1 | 2011 | 331 | 0.350 |
Why?
|
PTEN Phosphohydrolase | 1 | 2009 | 107 | 0.340 |
Why?
|
Kanamycin | 5 | 2013 | 11 | 0.340 |
Why?
|
Histones | 1 | 2009 | 111 | 0.330 |
Why?
|
Quality of Life | 1 | 2016 | 1514 | 0.330 |
Why?
|
Aspirin | 2 | 2006 | 295 | 0.320 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2019 | 137 | 0.310 |
Why?
|
Spiral Ganglion | 4 | 2016 | 47 | 0.300 |
Why?
|
Nerve Degeneration | 1 | 2006 | 134 | 0.280 |
Why?
|
Aminoglycosides | 3 | 2012 | 54 | 0.280 |
Why?
|
Tyrosine | 3 | 2015 | 195 | 0.260 |
Why?
|
Genetic Therapy | 2 | 2022 | 291 | 0.250 |
Why?
|
Aldehydes | 3 | 2015 | 34 | 0.230 |
Why?
|
Dependovirus | 1 | 2022 | 34 | 0.220 |
Why?
|
Genetic Vectors | 2 | 2022 | 310 | 0.220 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2022 | 4 | 0.220 |
Why?
|
Transduction, Genetic | 1 | 2022 | 81 | 0.220 |
Why?
|
Hearing | 2 | 2019 | 133 | 0.220 |
Why?
|
Caspase 9 | 2 | 2014 | 31 | 0.220 |
Why?
|
Reactive Oxygen Species | 4 | 2019 | 499 | 0.210 |
Why?
|
Hair | 1 | 2022 | 46 | 0.210 |
Why?
|
Cisplatin | 3 | 2011 | 192 | 0.210 |
Why?
|
Time Factors | 4 | 2016 | 4655 | 0.200 |
Why?
|
Down-Regulation | 2 | 2012 | 447 | 0.200 |
Why?
|
Superoxide Dismutase | 3 | 2006 | 149 | 0.190 |
Why?
|
Aminoacyltransferases | 1 | 2019 | 4 | 0.190 |
Why?
|
Glycosides | 1 | 2019 | 14 | 0.190 |
Why?
|
rac1 GTP-Binding Protein | 2 | 2012 | 23 | 0.190 |
Why?
|
Disease Models, Animal | 4 | 2012 | 2548 | 0.180 |
Why?
|
Epithelium | 1 | 2019 | 172 | 0.180 |
Why?
|
Lim Kinases | 1 | 2019 | 3 | 0.180 |
Why?
|
KCNQ Potassium Channels | 1 | 2019 | 8 | 0.180 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2016 | 1744 | 0.170 |
Why?
|
3T3 Cells | 1 | 2019 | 124 | 0.170 |
Why?
|
Drug Resistance, Bacterial | 1 | 2019 | 98 | 0.170 |
Why?
|
Escherichia coli | 1 | 2020 | 367 | 0.170 |
Why?
|
Calcium | 1 | 2022 | 927 | 0.160 |
Why?
|
Synapses | 2 | 2019 | 222 | 0.160 |
Why?
|
Phosphorylation | 3 | 2009 | 1197 | 0.160 |
Why?
|
Neomycin | 1 | 2017 | 56 | 0.150 |
Why?
|
Co-Repressor Proteins | 1 | 2016 | 8 | 0.150 |
Why?
|
Drug Administration Routes | 1 | 2016 | 25 | 0.150 |
Why?
|
Phosphoproteins | 2 | 2016 | 202 | 0.150 |
Why?
|
Histone Code | 1 | 2016 | 5 | 0.150 |
Why?
|
Alcohol Oxidoreductases | 1 | 2016 | 31 | 0.150 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2016 | 328 | 0.150 |
Why?
|
MAP Kinase Kinase Kinase 4 | 1 | 2016 | 1 | 0.140 |
Why?
|
Sensory Receptor Cells | 1 | 2016 | 9 | 0.140 |
Why?
|
Models, Biological | 2 | 2011 | 981 | 0.140 |
Why?
|
Receptors, AMPA | 1 | 2016 | 99 | 0.140 |
Why?
|
Acetylcysteine | 2 | 2017 | 296 | 0.140 |
Why?
|
Hydroxybenzoates | 2 | 2013 | 9 | 0.140 |
Why?
|
Histone Deacetylases | 1 | 2016 | 99 | 0.130 |
Why?
|
Pyrazoles | 1 | 2016 | 190 | 0.130 |
Why?
|
Pyrimidines | 1 | 2016 | 177 | 0.130 |
Why?
|
Antineoplastic Agents | 3 | 2011 | 1070 | 0.130 |
Why?
|
rhoA GTP-Binding Protein | 2 | 2012 | 37 | 0.130 |
Why?
|
Endodeoxyribonucleases | 1 | 2014 | 8 | 0.130 |
Why?
|
Gene Silencing | 1 | 2015 | 137 | 0.130 |
Why?
|
Caspase 8 | 1 | 2014 | 40 | 0.130 |
Why?
|
Microtubule-Associated Proteins | 1 | 2015 | 113 | 0.130 |
Why?
|
Cytoskeletal Proteins | 1 | 2015 | 108 | 0.130 |
Why?
|
Free Radical Scavengers | 2 | 2013 | 112 | 0.130 |
Why?
|
Ear Ossicles | 1 | 2013 | 2 | 0.120 |
Why?
|
Cell Line | 3 | 2017 | 1747 | 0.120 |
Why?
|
Oligopeptides | 1 | 2014 | 152 | 0.120 |
Why?
|
Lysophospholipids | 1 | 2015 | 209 | 0.120 |
Why?
|
Necrosis | 1 | 2014 | 239 | 0.120 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 710 | 0.120 |
Why?
|
Enzyme Inhibitors | 1 | 2016 | 658 | 0.120 |
Why?
|
Tympanic Membrane | 1 | 2012 | 25 | 0.110 |
Why?
|
Punctures | 1 | 2012 | 35 | 0.110 |
Why?
|
Cell Nucleus | 2 | 2011 | 303 | 0.110 |
Why?
|
Ear, Middle | 1 | 2012 | 32 | 0.110 |
Why?
|
Drug Interactions | 3 | 2009 | 289 | 0.110 |
Why?
|
Organ Culture Techniques | 2 | 2012 | 122 | 0.110 |
Why?
|
Injections | 1 | 2012 | 119 | 0.110 |
Why?
|
Ribosomes | 1 | 2012 | 23 | 0.110 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 282 | 0.110 |
Why?
|
NADPH Oxidases | 1 | 2012 | 80 | 0.110 |
Why?
|
Immunohistochemistry | 3 | 2011 | 1174 | 0.110 |
Why?
|
Mutation | 2 | 2016 | 1209 | 0.110 |
Why?
|
Mitochondria | 2 | 2017 | 643 | 0.100 |
Why?
|
HeLa Cells | 1 | 2011 | 237 | 0.100 |
Why?
|
Membrane Transport Proteins | 1 | 2011 | 81 | 0.100 |
Why?
|
Caspase 3 | 1 | 2011 | 233 | 0.100 |
Why?
|
Adenosine Triphosphate | 1 | 2012 | 314 | 0.100 |
Why?
|
RNA, Messenger | 3 | 2011 | 1650 | 0.100 |
Why?
|
Bacterial Infections | 1 | 2012 | 163 | 0.100 |
Why?
|
Carbohydrate Conformation | 2 | 2020 | 25 | 0.100 |
Why?
|
Membrane Proteins | 1 | 2015 | 617 | 0.100 |
Why?
|
Up-Regulation | 1 | 2012 | 682 | 0.090 |
Why?
|
Threonine | 1 | 2009 | 47 | 0.090 |
Why?
|
Microbial Sensitivity Tests | 2 | 2020 | 226 | 0.090 |
Why?
|
Blotting, Western | 2 | 2009 | 953 | 0.090 |
Why?
|
Humans | 6 | 2022 | 68504 | 0.090 |
Why?
|
Cyclooxygenase Inhibitors | 2 | 2006 | 72 | 0.090 |
Why?
|
Cytosol | 1 | 2009 | 121 | 0.090 |
Why?
|
Acetylation | 1 | 2009 | 94 | 0.090 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 134 | 0.090 |
Why?
|
Cochlear Microphonic Potentials | 1 | 2008 | 15 | 0.080 |
Why?
|
Cell Count | 1 | 2009 | 247 | 0.080 |
Why?
|
Hearing Loss, High-Frequency | 1 | 2008 | 16 | 0.080 |
Why?
|
Stria Vascularis | 1 | 2008 | 30 | 0.080 |
Why?
|
Longitudinal Studies | 1 | 2011 | 1054 | 0.080 |
Why?
|
Age Factors | 2 | 2011 | 1860 | 0.080 |
Why?
|
Disease Progression | 1 | 2011 | 1037 | 0.080 |
Why?
|
Severity of Illness Index | 1 | 2013 | 1851 | 0.080 |
Why?
|
Catalase | 2 | 2005 | 85 | 0.080 |
Why?
|
Cells, Cultured | 1 | 2012 | 2668 | 0.080 |
Why?
|
Apoptosis Inducing Factor | 1 | 2006 | 10 | 0.070 |
Why?
|
Phosphatidylinositols | 1 | 2006 | 40 | 0.070 |
Why?
|
Neurons | 1 | 2012 | 881 | 0.070 |
Why?
|
Neurons, Afferent | 1 | 2006 | 32 | 0.070 |
Why?
|
Free Radicals | 1 | 2006 | 65 | 0.070 |
Why?
|
Vestibule, Labyrinth | 1 | 2006 | 19 | 0.070 |
Why?
|
Salicylates | 2 | 2005 | 22 | 0.070 |
Why?
|
Female | 6 | 2016 | 38003 | 0.070 |
Why?
|
Trauma, Nervous System | 1 | 2005 | 6 | 0.070 |
Why?
|
Young Adult | 1 | 2016 | 5708 | 0.070 |
Why?
|
Sodium Salicylate | 1 | 2004 | 1 | 0.070 |
Why?
|
Adult | 2 | 2016 | 21373 | 0.060 |
Why?
|
Drugs, Chinese Herbal | 1 | 2003 | 15 | 0.060 |
Why?
|
Phenanthrenes | 1 | 2003 | 18 | 0.060 |
Why?
|
NF-kappa B | 1 | 2005 | 432 | 0.060 |
Why?
|
Double-Blind Method | 1 | 2006 | 1734 | 0.050 |
Why?
|
Biomarkers | 1 | 2006 | 1593 | 0.050 |
Why?
|
Aged | 1 | 2016 | 14841 | 0.050 |
Why?
|
Ethers | 1 | 2019 | 13 | 0.050 |
Why?
|
Carbohydrate Sequence | 1 | 2019 | 45 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2002 | 239 | 0.050 |
Why?
|
Nerve Tissue Proteins | 2 | 2016 | 290 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2002 | 307 | 0.040 |
Why?
|
Actin Depolymerizing Factors | 1 | 2019 | 16 | 0.040 |
Why?
|
Guinea Pigs | 2 | 2012 | 124 | 0.040 |
Why?
|
Mice, Transgenic | 2 | 2016 | 1031 | 0.040 |
Why?
|
Middle Aged | 1 | 2016 | 21115 | 0.040 |
Why?
|
Prospective Studies | 1 | 2006 | 3702 | 0.040 |
Why?
|
Autophagy-Related Proteins | 1 | 2017 | 17 | 0.040 |
Why?
|
Adenine | 1 | 2017 | 46 | 0.040 |
Why?
|
SOXB1 Transcription Factors | 1 | 2016 | 20 | 0.040 |
Why?
|
Tubulin | 1 | 2016 | 60 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 58 | 0.030 |
Why?
|
Embryo, Mammalian | 1 | 2016 | 176 | 0.030 |
Why?
|
Superoxides | 2 | 2006 | 70 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2016 | 396 | 0.030 |
Why?
|
Repressor Proteins | 1 | 2016 | 182 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2019 | 1692 | 0.030 |
Why?
|
Rats, Inbred F344 | 2 | 2004 | 104 | 0.030 |
Why?
|
Reticulocytes | 1 | 2012 | 7 | 0.030 |
Why?
|
Mycobacterium | 1 | 2012 | 12 | 0.030 |
Why?
|
Mutagenesis | 1 | 2012 | 60 | 0.030 |
Why?
|
Drug Design | 1 | 2012 | 107 | 0.030 |
Why?
|
Protein Biosynthesis | 1 | 2012 | 178 | 0.030 |
Why?
|
Rabbits | 1 | 2012 | 509 | 0.030 |
Why?
|
Cell Differentiation | 1 | 2016 | 1034 | 0.030 |
Why?
|
Pseudomonas aeruginosa | 1 | 2012 | 133 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2012 | 325 | 0.030 |
Why?
|
Staphylococcus aureus | 1 | 2012 | 175 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2011 | 244 | 0.020 |
Why?
|
Bacteria | 1 | 2012 | 193 | 0.020 |
Why?
|
Binding Sites | 1 | 2012 | 630 | 0.020 |
Why?
|
Pregnancy | 1 | 2016 | 2331 | 0.020 |
Why?
|
Cytoplasm | 1 | 2006 | 155 | 0.020 |
Why?
|
Cytoskeleton | 1 | 2006 | 84 | 0.020 |
Why?
|
DNA Replication Timing | 1 | 2005 | 1 | 0.020 |
Why?
|
Synaptotagmin I | 1 | 2005 | 1 | 0.020 |
Why?
|
Synaptotagmins | 1 | 2005 | 3 | 0.020 |
Why?
|
Cell Fractionation | 1 | 2005 | 34 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2005 | 60 | 0.020 |
Why?
|
Iron Chelating Agents | 1 | 2005 | 31 | 0.020 |
Why?
|
Rats | 2 | 2004 | 5282 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2005 | 132 | 0.020 |
Why?
|
Protective Agents | 1 | 2005 | 36 | 0.020 |
Why?
|
Drosophila Proteins | 1 | 2005 | 44 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2005 | 114 | 0.020 |
Why?
|
Molecular Chaperones | 1 | 2005 | 81 | 0.020 |
Why?
|
Polymers | 1 | 2006 | 244 | 0.020 |
Why?
|
Benzimidazoles | 1 | 2005 | 128 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2005 | 567 | 0.020 |
Why?
|
Hydroxyl Radical | 1 | 2003 | 17 | 0.010 |
Why?
|
Oxidants | 1 | 2003 | 48 | 0.010 |
Why?
|
Adenoviridae | 1 | 2004 | 295 | 0.010 |
Why?
|
Lipid Peroxidation | 1 | 2003 | 94 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2005 | 789 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2005 | 229 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2006 | 596 | 0.010 |
Why?
|
Drug Antagonism | 1 | 2002 | 6 | 0.010 |
Why?
|
Neural Conduction | 1 | 2002 | 24 | 0.010 |
Why?
|
Blood Urea Nitrogen | 1 | 2002 | 65 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2005 | 370 | 0.010 |
Why?
|
Kidney Function Tests | 1 | 2002 | 114 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2006 | 929 | 0.010 |
Why?
|
Neoplasms, Experimental | 1 | 2002 | 118 | 0.010 |
Why?
|
Rats, Wistar | 1 | 2002 | 371 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2005 | 2789 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2002 | 1531 | 0.010 |
Why?
|